The Discounted Cash Flow (DCF) valuation of Bio-Works Technologies AB (BIOWKS.ST) is (278.49) SEK. With the latest stock price at 2.10 SEK, the upside of Bio-Works Technologies AB based on DCF is -13361.6%.
Based on the latest price of 2.10 SEK and our DCF valuation, Bio-Works Technologies AB (BIOWKS.ST) is a sell. selling BIOWKS.ST stocks now will result in a potential gain of 13361.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 7.0% | 6.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (650.27) - (179.99) | (278.49) |
| Upside | -31065.4% - -8670.9% | -13361.6% |